Literature DB >> 21081777

A clinical evaluation of the intubating laryngeal airway as a conduit for tracheal intubation in children.

Narasimhan Jagannathan1, Ryan J Kozlowski, Lisa E Sohn, Kenneth E Langen, Andrew G Roth, Isabella I Mukherji, Melanie F Kho, Santhanam Suresh.   

Abstract

BACKGROUND: The air-Q Intubating Laryngeal Airway (ILA) (Cookgas LLC, Mercury Medical, Clearwater, FL) is a supraglottic airway device available in pediatric sizes, with design features to facilitate passage of cuffed tracheal tubes when used to guide tracheal intubation. We designed this prospective observational study of the ILA to assess the ease of its placement in paralyzed pediatric patients, determine its position and alignment to the larynx using a fiberoptic bronchoscope, gauge its efficacy as a conduit for fiberoptic intubation with cuffed tracheal tubes, and evaluate the ability to remove the ILA without dislodgement of the tracheal tube after successful tracheal intubation.
METHODS: One hundred healthy children, aged 6 months to 8 years, ASA physical status I to II, and scheduled for elective surgery requiring general endotracheal anesthesia were enrolled in this prospective study. Based on the manufacturer's guidelines, each patient received either a size 1.5 or 2.0 ILA according to their weight. The number of attempts for successful insertion, leak pressures, fiberoptic grade of view, number of attempts and time for tracheal intubation, time for ILA removal, and complications were recorded.
RESULTS: ILA placement, fiberoptic tracheal intubation, and ILA removal were successful in all patients. The size 1.5 ILA cohort had significantly higher rates of epiglottic downfolding compared with the size 2.0 ILA cohort (P < 0.001), despite adequate ventilation variables. When comparing fiberoptic grade of view to weight, a moderate negative correlation was found (r = -0.41, P < 0.001), indicating that larger patients tended to have better fiberoptic grades of view. The size 1.5 ILA cohort had a significantly longer time to intubation (P = 0.04) compared with the size 2.0 ILA cohort. However, this difference may not be clinically significant because there was a large overlap of confidence bounds in the average times of the size 1.5 ILA (27.0 ± 13.0 seconds) and size 2.0 ILA cohorts (22.7 ± 6.9 seconds). When comparing weight to time to tracheal intubation, a weak correlation that was not statistically significant was found (r = -0.17, P = 0.09), showing that time to intubation did not differ significantly according to weight, despite higher fiberoptic grades in smaller patients.
CONCLUSIONS: The ILA was easy to place and provided an effective conduit for tracheal intubation with cuffed tracheal tubes in children with normal airways. Additionally, removal of the ILA after successful intubation could be achieved quickly and without dislodgement of the tracheal tube. Because of the higher incidence of epiglottic downfolding in smaller patients, the use of fiberoptic bronchoscopy is recommended to assist with tracheal intubation through this device.

Entities:  

Mesh:

Year:  2010        PMID: 21081777     DOI: 10.1213/ANE.0b013e3181fe0408

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  11 in total

1.  Surgical airways for trauma patients in an emergency surgical setting: 11 years' experience at a teaching hospital in Japan.

Authors:  Yuko Ono; Hideyuki Yokoyama; Akinori Matsumoto; Yoshibumi Kumada; Kazuaki Shinohara; Choichiro Tase
Journal:  J Anesth       Date:  2013-05-18       Impact factor: 2.078

2.  Supraglottic airway devices in children.

Authors:  S Ramesh; R Jayanthi
Journal:  Indian J Anaesth       Date:  2011-09

3.  Performance of size 1 I-gel compared with size 1 ProSeal laryngeal mask in anesthetized infants and neonates.

Authors:  Gulay Erdogan Kayhan; Zekine Begec; Mukadder Sanli; Ender Gedik; Mahmut Durmus
Journal:  ScientificWorldJournal       Date:  2015-02-22

4.  Comparison of the air-Q intubating laryngeal airway and the cobra perilaryngeal airway as conduits for fiber optic-guided intubation in pediatric patients.

Authors:  Karim K Girgis; Maha M I Youssef; Nashwa S ElZayyat
Journal:  Saudi J Anaesth       Date:  2014-10

Review 5.  Comparative Efficacy of the Air-Q Intubating Laryngeal Airway during General Anesthesia in Pediatric Patients: A Systematic Review and Meta-Analysis.

Authors:  Eun Jin Ahn; Geun Joo Choi; Hyun Kang; Chong Wha Baek; Yong Hun Jung; Young Cheol Woo; Si Ra Bang
Journal:  Biomed Res Int       Date:  2016-06-23       Impact factor: 3.411

6.  Blind Tracheal Intubation through the Air-Q Intubating Laryngeal Airway in Pediatric Patients: Reevaluation - A Randomized Controlled Trial.

Authors:  El-Sayed M El-Emam; Enas A Abd El Motlb
Journal:  Anesth Essays Res       Date:  2019 Apr-Jun

7.  Comparison of Air-QⓇ insertion techniques in pediatric patients with fiber-optic bronchoscopic assessment: a prospective randomized control trial.

Authors:  Manasa Gaddam; Sameer Sethi; Aditi Jain; Vikas Saini
Journal:  Korean J Anesthesiol       Date:  2019-06-04

8.  Canadian Airway Focus Group updated consensus-based recommendations for management of the difficult airway: part 2. Planning and implementing safe management of the patient with an anticipated difficult airway.

Authors:  J Adam Law; Laura V Duggan; Mathieu Asselin; Paul Baker; Edward Crosby; Andrew Downey; Orlando R Hung; George Kovacs; François Lemay; Rudiger Noppens; Matteo Parotto; Roanne Preston; Nick Sowers; Kathryn Sparrow; Timothy P Turkstra; David T Wong; Philip M Jones
Journal:  Can J Anaesth       Date:  2021-06-08       Impact factor: 5.063

9.  Use of proseal™ LMA in mallampati class zero.

Authors:  Sheetal Chiplonkar; Pratibha Toal; Jalpa Kate; Apeksha Shah
Journal:  Indian J Anaesth       Date:  2012-11

10.  A cohort evaluation of clinical use and performance characteristics of Ambu® AuraGain™: A prospective observational study.

Authors:  Devangi A Parikh; Ruchi A Jain; Smita S Lele; Bharati A Tendolkar
Journal:  Indian J Anaesth       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.